I am a globally trained physician–scientist, health policy leader, social entrepreneur, and executive building responsible brain health innovation ecosystems.

I currently lead the NeuroTech Open Innovation Hub  at the Charité BIH ARC Innovation Center, building a Berlin-based innovation ecosystem that connects care delivery and patient communities, academia, neurotechnology startups, funders, and policy and regulatory stakeholders to translate innovation into clinically meaningful, ethically grounded, equitable, and system-ready impact.

Previously, I served as Technical Consultant at the World Health Organization (Brain Health Unit), leading the coordination and development of WHO's first Global Status Report on Neurology. I also headed Policy and Research at the International Bureau for Epilepsy, directing global implementation initiatives, and co-founded the non-profit organization R3SOLUTE, serving as its Chief Medical Officer. I trained and worked as a physician–scientist at Charité – Universitätsmedizin Berlin and am an Affiliate Researcher at Mass General Brigham Cancer Institute, Harvard Medical School.

My work has been published in leading journals including The Lancet, JAMA, Neurology, Neuro-Oncology, AI & Ethics, and Brookings Institution Press. I hold academic and research affiliations with Charité – Universitätsmedizin Berlin and the Mass General Brigham Cancer Institute, Harvard Medical School, and serve as Commissioner for the Lancet Commission on Neurorehabilitation and Senior Editor of the forthcoming Springer Nature Textbook Neurotoxicity in Cancer Therapy.

An alumnus of the German National Academic Foundation, I hold a Ph.D. (summa cum laude) and M.D. (with distinction) from Charité, as well as a B.Sc. in Neuroscience (First Class Honours) from King’s College London.

Focus: neurotechnology & brain health ecosystems, science-for-policy, public–private partnerships, global-to-local orchestration, and responsible innovation.